News Anklam Extrakt® declaration of consent for newsletter subscription

Our free newsletter keeps you up to date with everything currently happening in our company. I consent to Anklam Extrakt GmbH sending me a newsletter from time to time, to the specified e-mail address. My personal data (surname, first name, e-mail address) may be stored and used/processed for customer communication by Anklam Extrakt GmbH. We use rapidmail to distribute our newsletter. For this reason, your data are transmitted to rapidmail GmbH. rapidmail GmbH is prohibited from using your data for any other purposes than distributing the newsletter. rapidmail GmbH is prohibited from disclosing or selling your data. With each newsletter, you are given the option of cancelling your subscription. In addition, you have the right to request deletion of all your data and restriction of data processing under certain conditions. For further details click here.

Anklam Extrakt® is a member of:

Anklam Extrakt® wins NutraIngredients Award 2019 for optibright®

Our recently launched private label product optibright® is the winner of this year’s #NIAwards19 in the category Omega-3 product of the year. The judges were impressed by the good level of scienti ...

optibright® - Finalist of the NutraIngredients Award for "Omega-3 Product of the Year"

Our newly launched product concept optibright® has been selected as a finalist for this year’s NutraIngredients Awards in the category "Omega-3 Product of the Year". optibright® is an oral supplem ...

Science News | Maquiberry Extract

Anklam Extrakt® continuously puts great emphasis on scientific research of their extracts, to prove the efficacy and to provide customers an added value. At the end of 2018 our latest clinical ...

Anklam Extrakt® at SupplySide West 2018 in Las Vegas

Last week Anklam Extrakt® attended SupplySide West in Las Vegas. We had a couple of eventful days, including a presentation from our Research Manager Stefanie Lang, PhD about our newest Branded Ingre ...

C² PHARMA and ANKLAM EXTRAKT® announce R&D collaboration to develop cannabidiol-based compounds

  C² PHARMA is implementing its cannabis strategy by collaborating with ANKLAM EXTRAKT®, a European-based manufacturer of botanical extracts with full GMP accreditations from the German authoriti ...

ANKLAM EXTRAKT wants to say thank you!

Dear reader, We are looking back happily to the Vitafoods Europe 2018 trade fair which was very eventful and successful for us. In addition to many interesting conversations, there were further highl ...

ANKLAM EXTRAKT goes Vitafoods Europe 2018

Dear reader, We are excited to see you at the Vitafoods Europe 2018 and would like to extend a warm welcome on our stand D39 . Our experts are pleased to inform you about Anklam Extrakt, our products, ...